Two of the five horses which ran loose through London are in a ‘serious condition’
This comes after a total of five Army horses were seen galloping through the streets of London on Wednesday, with four soldiers injured, after being thrown by them.
Sainsbury’s predicts profit to exceed £1bn as Aldi price-matching pays off
Supermarket Sainsbury’s expects profits to exceed £1bn this year as it continues to win shoppers with loyalty card and Aldi price matching schemes.
Drax trading on track for the year as it awaits Westminster’s carbon capture sign-off
Drax awaits the green light from the government on a bridging mechanism for its carbon capture project
London Stock Exchange owner’s growth meets estimates as it leans into Microsoft data deal
The London Stock Exchange Group (LSEG) has reported first-quarter growth in line with analysts' estimates as it plans to start releasing products from its tie-up with Microsoft in the coming months.
WPP expects to return to growth in second-half as AI tools ‘deployed at scale’
For the full year, the company said it expected to report like-for-like revenue growth less pass-through costs of zero to one per cent.
Unilever thanks ‘power brands’ for sales bump as Marmite-maker steams ahead with turnaround plan
Consumer giant Unilever said sales of its most popular brands such as Dove soap helped drive growth in the first quarter, in the businesses first trading update since announcing plans to sell its ice-
Hipgnosis bidding battle hots up as Concord pips Blackstone bid
This comes after Blackstone the board of Hipgnosis had said it would be “minded” to switch horses in a takeover battle should a firm offer from US private equity giant Blackstone arrive, over the
Barclays shares hit two-year high after profit beats estimates, but investment bank struggles
Barclays has reported an 11 per cent drop in profit - slightly outperforming analysts' estimates - as the boost from higher interest rates fades and its investment bank struggles to compete with its W
Astrazeneca’s revenue surges as pipeline investments pay off
Pascal Soriot, chief executive officer of AstraZeneca, said: "Astrazeneca had a very strong start in 2024 with substantial total revenue growth of 19 per cent in the first quarter.
Mark Kleinman: A remix at Hipgnosis and accountancy drama
Mark Kleinman gets the City talking with his weekly column